1Sorensen IA,Nielsen GG,Andersen PK,et al.Genetic and environmental influences on premature death in adult adoptees[J].N Engl J Med,1988,318:727-732.
2Mira JP,Cariou A,Grall F,et al.Association of TNF2,a TNF-alpha promoter polymor-phism,with septic shock susceptibility and mortality:A multicenter study[ J ].JAMA,1999,282:561-568.
3Cohen J,Cristofaro P,Carlet J,et al.A new system of classification of infection[J].Crit Care Med,2004,32:1510-1526.
4Opal SM,Cohen J.Clinical gram-positive sepsis:Does it fundamentally differ from gram-negative bacterial sepsis? [ J ].Crit Care Med,1999,27:1608-1616.
5Ziegler EJ,Fisher CJ Jr,Sprung CL,et al.Treatment of Gramnegative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin:A randomized,double-blind,placebo-controlled trial[J ].N Engl J Med,1991,324:429-436.
6Wortel CH,von der Mohlen MAM,van Deventer SJH,et al.Effectiveness of a human monoclonal anti-endotoxin antibody (HA1A) in gram-negative sepsis:Relationship to endotoxin and cytokine levels[J].J Infect Dis,1992,166:1367-1374.
7McCloskey RV,Straube RC,Sanders C,et al.Treatment of septic shock with human monoclonal antibody HA-1A:A randomized,double-blind,placebo-controlled trial[J].Ann Intern Med,1994,121:1-5.
8Bernard GR,Vincent JL,Laterre PF,et al.Efficacy and safety of recombinant human activated protein C for severe sepsis[J ].N Engl J Med,2001,344:699-709.
9Annane D,Sebille V,Charpentier C,et al.Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock[J].JAMA,2002,288:862-871.
10Marshall JC,Panacek EA,Teoh L,et al.Modeling organ dysfunction as risk factor,outcome,and measure of biologic effect in sepsis[ J ].Crit Care Med,2001,28:A46.
